Volume 18, Number 5—May 2012
Research
Bartonella spp. Bacteremia and Rheumatic Symptoms in Patients from Lyme Disease–endemic Region
Ricardo G. Maggi, B. Robert Mozayeni, Elizabeth L. Pultorak, Barbara C. Hegarty, Julie M. Bradley, Maria Correa, and Edward B. Breitschwerdt
Table 2
Test results for Bartonella spp. in 296 patients examined by a rheumatologist, Maryland–Washington, DC, USA, August 25, 2008–April 1, 2009*
| Bartonella sp. | IFA–/PCR– | IFA+/PCR– | IFA+/PCR+ | IFA–/PCR+ |
|---|---|---|---|---|
| B. henselae | 196 | 60 | 7 | 33 |
| B. koehlerae | 177 | 65 | 24 | 29 |
| B. vinsonii subsp. berkhoffii | 141 | 145 | 3 | 7 |
| Genotype I | 217 | 75 | 2 | 1 |
| Genotype II | 189 | 101 | 1 | 5 |
| Genotype III | 213 | 82 | 0 | 0 |
*IFA, indirect immunofluorescent antibody results obtained by using B. henselae, B. koehlerae, and B. vinsonii subsp. berkhoffii antigens; PCR, results obtained after PCR amplification by using Bartonella intergenic spacer primers, followed by attempted DNA sequencing of each amplicon.
Page created: April 12, 2012
Page updated: April 12, 2012
Page reviewed: April 12, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.